Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT.

Stögbauer, Louise; Thomas, Christian; Wagner, Andrea; Warneke, Nils; Bunk, Eva Christine; Grauer, Oliver; Canisius, Julian; Paulus, Werner; Stummer, Walter; Senner, Volker; Brokinkel, Benjamin

Stögbauer, Louise; Thomas, Christian; Wagner, Andrea; Warneke, Nils; Bunk, Eva Christine; Grauer, Oliver; Canisius, Julian; Paulus, Werner; Stummer, Walter; Senner, Volker; Brokinkel, Benjamin.

Afiliação

Stögbauer L; 1Department of Neurosurgery.
Thomas C; 2Institute of Neuropathology, and.
Wagner A; 1Department of Neurosurgery.
Warneke N; 1Department of Neurosurgery.
Bunk EC; 1Department of Neurosurgery.
Grauer O; 3Department of Neurology, University Hospital Münster, North Rhine-Westphalia, Germany.
Canisius J; 1Department of Neurosurgery.
Paulus W; 2Institute of Neuropathology, and.
Stummer W; 1Department of Neurosurgery.
Senner V; 2Institute of Neuropathology, and.
Brokinkel B; 1Department of Neurosurgery.

J Neurosurg ; 135(3): 845-854, 2020 Dec 11.

Article em En | MEDLINE | ID: mdl-33307532

Palavras-chave

decitabine; hTERT; human telomerase reverse transcriptase; meningioma; methylation; oncology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Neurosurg Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Neurosurg Ano de publicação: 2020 Tipo de documento: Article